Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aricept in Parkinson's Disease Patients With Dementia
NCT00165815Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of donepezil in Parkinson's disease dementia (PDD) (3 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Alzheimer's Disease Assessment Scale-cognitive subscale at 16 weeks and Clinician's Interview-Based Impression of Change plus caregiver input at 16 weeks. Started Aug 2002; status: completed.
02
Drugs
donepezil
03
Conditions
Parkinson's disease dementia (PDD)
Beyond the preview
Go deeper on NCT00165815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165815.